| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2542999 | Journal of the American Pharmacists Association | 2015 | 10 Pages |
Abstract
SB41 has not resulted in broad pharmacy-based syringe access in California's inland counties, where a disproportionate number of cases of human immunodeficiency virus (HIV) infections are associated with injection drug use. Additional steps by legislative bodies, regulatory agencies, and professional organizations are needed to actively engage pharmacies in expanding nonprescription syringe sales to reduce HIV transmission among injection drug users.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Robin A. (Senior Research Scientist), Abby E. (Research Scientist), Patricia (Research Associate Professor),